Company performance
Add to research
Current Price
as of Mar 12, 2025$15.00
P/E Ratio
4.50
Market Cap
$3.86B
Loading...
Description
Add to research
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Metrics
Add to research
Overview
- HQJersey City, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerOGN
- Price$15-3.85%
Trading Information
- Market cap$3.86B
- Float99.73%
- Average Daily Volume (1m)3,454,280
- Average Daily Volume (3m)3,544,569
- EPS$3.36
Company
- Revenue$6.40B
- Rev growth (1yr)2.24%
- Net income$864.00M
- Gross margin58.02%
- EBITDA margin27.72%
- EBITDA$1.78B
- EV$12.23B
- EV/Revenue1.91
- P/E4.50
- P/S0.61
- P/B8.19
- Debt/Equity1,914.41
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account